Tg Therapeutics TGTX
NASDAQ TGTX
$56.83 +0.65 (+1.15%)
As of: Sep 30, 2026 · 1:42 PM EDT

Tg Therapeutics, Inc. (TGTX) EBT (2011 - 2026)

Updated

Tg Therapeutics (TGTX) posted EBT of $10.23 million for Q2 2026, down 66.9% from $30.92 million a year earlier and down 49.7% from the prior quarter.

Analysis

Tg Therapeutics, Inc. (TGTX) EBT (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBT at Tg Therapeutics was $101.6 million, up 53.7% year-over-year; for FY2025, it was $107.39 million, up 319.6% from FY2024.

  • In prior years, Tg Therapeutics' EBT was $25.59 million in FY2024 (+95.9%), $13.06 million in FY2023, -$223.81 million in FY2022 and -$348.1 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly EBT since Q1 2025.
  • On a year-over-year basis, EBT increased in four of the last six quarters, with growth averaging 177.6%.
  • According to Business Quant data, EBT for the three prior quarters was $20.36 million (Q1 2026), $45.09 million (Q4 2025) and $25.91 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.23 Mn
Mar 31, 2026 20.36 Mn
Dec 31, 2025 45.09 Mn
Sep 30, 2025 25.91 Mn
Jun 30, 2025 30.92 Mn
Mar 31, 2025 5.47 Mn
Dec 31, 2024 25.45 Mn
Sep 30, 2024 4.27 Mn
Jun 30, 2024 6.55 Mn
Mar 31, 2024 -10.68 Mn
Dec 31, 2023 -14.03 Mn
Sep 30, 2023 113.93 Mn
Jun 30, 2023 -47.61 Mn
Mar 31, 2023 -39.23 Mn
Dec 31, 2022 -80.40 Mn
Sep 30, 2022 -36.61 Mn
Jun 30, 2022 -41.96 Mn
Mar 31, 2022 -76.94 Mn
Dec 31, 2021 -98.63 Mn
Sep 30, 2021 -86.17 Mn
API Access

Tg Therapeutics, Inc. EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=TGTX&period=max&api_key=YOUR_API_KEY